While the low prevalence, in comparison to mainland Spain, has prevented the saturation of the health system, this low prevalence translates into low immunization rates, therefore facilitating the propagation of new outbreaks that could lead to secondary waves of COVID-19 in the region. These findings warn about scenarios regarding…[Read more]

P. jirovecii was detected in 19% [95% confidence interval (CI) 12-27%] of 3583 symptomatic and in 9% [95% CI 0-45%] of 140 asymptomatic adults. Among symptomatic adults, prevalence was 22% [95% CI 12-35%] by PCR and 15% [95% CI 9-23%] by microscopy. Seven percent of 435 symptomatic adults had PCR-detected Pneumocystis colonization without evidence…[Read more]

In response to the U.S. opioid epidemic, the HEALing (Helping to End Addiction Long-term

) Communities Study (HCS) is a multisite, wait-listed, community-level cluster-randomized trial that aims to test the novel Communities That HEAL (CTH) intervention, in 67 communities. CTH will expand an integrated set of evidence-based practices (EBPs)…[Read more]